Incannex Healthcare Inc ADR (IXHL) Stock Price, Quote & News

Company Profile

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety diso...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 61 4 0984 0786

Website: www.incannex.com

Address:

8 Century Circuit, Suite 105 Norwest, Sydney, Australia

SeamuSMingluS Aug. 19 at 1:03 PM

$IXHL Resonating narrative Mechanism of action OSA FDA AND Commercial discussions update in this regard soon 1600%% inbound I just woke up got to go work at the Clinic but first i need to have a big stick brown JDawg after my coffeee

0 · Reply

Wildacorn Aug. 19 at 12:55 PM

$IXHL 💥Boom Time💥 - 🚀

0 · Reply

mku Aug. 19 at 12:48 PM

$IXHL 22.04.2027, 8 AM E.T. 👀

0 · Reply

D_Ko Aug. 19 at 12:09 PM

$IXHL

0 · Reply

Awesomeaastroem Aug. 19 at 12:08 PM

$IXHL sooo… how long are we going to have to wait for the first patient dosed? Shouldn’t it have happened already?

1 · Reply

SeamuSMingluS Aug. 19 at 12:02 PM

$IXHL 93m USD for Aprix Whats that all about? But you lookon the books theres ZERO rd value? What happened to all those pathways. Man that was alot of shares given for a pile of worthless shit imo. Who signed off on that? You would need at least 20+ yrs senior management experience to pull that off. Only a Mars bar gambling smoker could bet this would be a success But seriously who valued Aprix IP ? ISNT it a pile of old dead AXIM shit? Who knows my AI tells me this is s very interesting case of Capitous Shelleous A trap. Least we can be sure of one thing. ......

0 · Reply

RyanWxm1 Aug. 19 at 11:35 AM

$IXHL did 1600% happen in July 😜

0 · Reply

stockro1 Aug. 19 at 11:34 AM

$IXHL this is a very fair judgement.

1 · Reply

LSB73 Aug. 19 at 10:47 AM

$IXHL - statistically the timing feels bloody close now. 42X screening underway and first dose is surely getting close. PSX-001 sitting there with strong P2 GAD data, P2b cleared and partnership language still swinging. If both programs light up around the same time on our featherweight $40M MC… could be a flamethrower. Fuck I’d love to see a squeeze.

1 · Reply

SeamuSMingluS Aug. 19 at 2:18 AM

$IXHL Breath Relax SH latest IR/PR has got me excieted. Theres Commercial discussions happening all the time regarding the Pathways that we not currently developing 🤔🤔🤔 Great that the huge SH investment in the acquisition of APRix wasn't a total waste. Wonder what of those 28 pathways they are interested in. How many have even been tested on humans.? 1600% inbound

0 · Reply

Incannex receives additional A$5.1M R&D tax incentive refund

2026-07-23T12:10:52.000Z - 27 days ago

Incannex commences screening in DReAMzz trial

Jul 23, 2026, 8:00 AM EDT - 27 days ago

Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea

2026-06-25T12:10:38.000Z - 7 weeks ago

Incannex granted IHL-42X composition patent by USPTO

Jun 25, 2026, 8:00 AM EDT - 7 weeks ago

Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea

2026-06-10T12:06:25.000Z - 2 months ago

Incannex receives A$6.04M tax incentive refund

Jun 10, 2026, 8:00 AM EDT - 2 months ago

Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility

Jun 9, 2026, 8:00 AM EDT - 2 months ago

Incannex Announces Initiation of Research Coverage by Alliance Global Partners

2026-06-08T11:05:32.000Z - 2 months ago

Incannex initiated with a Buy at Alliance Global

May 15, 2026, 7:00 AM EDT - 3 months ago

Incannex Healthcare Quarterly report: Q3 2026

2026-05-14T19:10:49.000Z - 3 months ago

Incannex commences DReaMzz clinical study of IHL-42X in OSA

May 14, 2026, 10:35 AM EDT - 3 months ago

Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea

May 12, 2026, 8:00 AM EDT - 3 months ago

Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development

May 7, 2026, 10:00 AM EDT - 3 months ago

Incannex Healthcare Recognized for Innovative Drug Development Solutions by MedTech Breakthrough

Apr 22, 2026, 8:00 AM EDT - 4 months ago

Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness

2026-03-27T12:12:54.000Z - 5 months ago

Incannex reactivates share repurchase program

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position

2026-03-25T12:11:47.000Z - 5 months ago

Incannex enters partnership agreement with American Academy of Sleep Medicine

Mar 25, 2026, 8:00 AM EDT - 5 months ago

Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research

2026-03-18T12:27:15.000Z - 5 months ago

Incannex reports balance sheet with $75M in cash, no debt

Mar 18, 2026, 8:00 AM EDT - 5 months ago

Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development

2026-03-17T12:16:04.000Z - 5 months ago

Incannex regains compliance with Nasdaq minimum bid price rule

Mar 17, 2026, 8:00 AM EDT - 5 months ago

Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement

2026-03-12T12:27:43.000Z - 5 months ago

Incannex prices 2M shares at $5.00 in registered direct offering

2026-03-12T12:21:15.000Z - 5 months ago

Incannex announces enhanced development strategy for IHL-42X

Mar 12, 2026, 8:05 AM EDT - 5 months ago

Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

2026-02-27T00:50:18.000Z - 6 months ago

Incannex Healthcare Inc trading halted, news pending

2026-02-25T14:29:04.000Z - 6 months ago

Incannex board approves 1-for-30 reverse stock split

Feb 25, 2026, 9:20 AM EST - 6 months ago

Incannex Announces Reverse Stock Split

Feb 20, 2026, 6:00 AM EST - 6 months ago

Incannex Healthcare Slides: Investor presentation

Feb 18, 2026, 6:35 PM EST - 6 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2026

Feb 13, 2026, 7:00 AM EST - 6 months ago

Incannex Healthcare Quarterly report: Q2 2026

2026-01-29T13:16:52.000Z - 7 months ago

Incannex announces additional appointments to Clinical Advisory Board

Jan 29, 2026, 8:00 AM EST - 7 months ago

Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board

Jan 22, 2026, 8:00 AM EST - 7 months ago

Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program

Jan 15, 2026, 8:00 AM EST - 7 months ago

Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards

Jan 14, 2026, 8:00 AM EST - 7 months ago

Incannex Healthcare Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026

Dec 18, 2025, 7:00 AM EST - 8 months ago

Incannex Healthcare Proxy statement: Proxy Filing

Dec 16, 2025, 7:00 AM EST - 8 months ago

Incannex Healthcare Proxy statement: Proxy Filing

Dec 3, 2025, 8:00 AM EST - 9 months ago

Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA)

Nov 20, 2025, 9:34 AM EST - 9 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2026

Nov 14, 2025, 4:00 PM EST - 9 months ago

Incannex Healthcare Quarterly report: Q1 2026

Oct 30, 2025, 8:00 AM EDT - 10 months ago

Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus

Oct 27, 2025, 8:00 AM EDT - 10 months ago

Incannex Healthcare Proxy statement: Proxy Filing

Oct 27, 2025, 8:00 AM EDT - 10 months ago

Incannex Healthcare Proxy statement: Proxy Filing

Oct 22, 2025, 8:00 AM EDT - 10 months ago

Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Sep 29, 2025, 9:30 AM EDT - 11 months ago

Incannex Healthcare Annual report: Q4 2025

Aug 26, 2025, 8:00 AM EDT - 1 year ago

Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder

Aug 22, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Authorizes $20 Million Share Repurchase Program

Aug 19, 2025, 4:29 PM EDT - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea

Jul 31, 2025, 8:00 AM EDT - 1 year ago

Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term

Jul 30, 2025, 8:00 AM EDT - 1 year ago

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Jul 25, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Jun 24, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Jun 18, 2025, 7:30 AM EDT - 1 year ago

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

Jun 17, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Jun 12, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Jun 3, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

May 29, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

May 28, 2025, 4:21 PM EDT - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025

May 28, 2025, 7:00 AM EDT - 1 year ago

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

May 20, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

May 16, 2025, 9:00 AM EDT - 1 year ago

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

May 16, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing

May 15, 2025, 9:30 AM EDT - 1 year ago

Incannex Healthcare Earnings release: Q3 2025

May 15, 2025, 9:30 AM EDT - 1 year ago

Incannex Healthcare Quarterly report: Q3 2025

May 15, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

May 14, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing

Apr 16, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Registration statement: Registration Filing

Apr 3, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Registration statement: Registration Filing

Mar 18, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing

Mar 7, 2025, 2:10 PM EST - 1 year ago

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Feb 18, 2025, 5:51 PM EST - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Feb 14, 2025, 7:30 AM EST - 1 year ago

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Feb 14, 2025, 7:00 AM EST - 1 year ago

Incannex Healthcare Earnings release: Q2 2025

Feb 14, 2025, 7:00 AM EST - 1 year ago

Incannex Healthcare Quarterly report: Q2 2025

Feb 4, 2025, 9:15 AM EST - 1 year ago

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

Jan 23, 2025, 7:30 AM EST - 1 year ago

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

Dec 2, 2024, 4:48 PM EST - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Nov 26, 2024, 7:00 AM EST - 1 year ago

Incannex Healthcare Registration statement: Registration Filing

Nov 14, 2024, 4:05 PM EST - 1 year ago

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

SeamuSMingluS Aug. 19 at 1:03 PM

0 · Reply

Wildacorn Aug. 19 at 12:55 PM

$IXHL 💥Boom Time💥 - 🚀

0 · Reply

mku Aug. 19 at 12:48 PM

$IXHL 22.04.2027, 8 AM E.T. 👀

0 · Reply

D_Ko Aug. 19 at 12:09 PM

$IXHL

0 · Reply

Awesomeaastroem Aug. 19 at 12:08 PM

$IXHL sooo… how long are we going to have to wait for the first patient dosed? Shouldn’t it have happened already?

1 · Reply

SeamuSMingluS Aug. 19 at 12:02 PM

0 · Reply

RyanWxm1 Aug. 19 at 11:35 AM

$IXHL did 1600% happen in July 😜

0 · Reply

stockro1 Aug. 19 at 11:34 AM

$IXHL this is a very fair judgement.

1 · Reply

LSB73 Aug. 19 at 10:47 AM

1 · Reply

SeamuSMingluS Aug. 19 at 2:18 AM

0 · Reply

Yas29 Aug. 19 at 2:16 AM

$IXHL Any new news ?

1 · Reply

No_earnings Aug. 18 at 10:29 PM

$IXHL got a gap to fill 🫡

0 · Reply

RogueFF7 Aug. 18 at 9:22 PM

$IXHL Extremely

0 · Reply

BULLY83 Aug. 18 at 9:21 PM

$IXHL is stanky feet jana still posting here?

1 · Reply

SeamuSMingluS Aug. 18 at 8:32 PM

$IXHL 1600% Inbound Heterogeneous Pathways to innovation Breath Breathe

0 · Reply

IldijanaMM Aug. 18 at 8:07 PM

$IXHL Very very

0 · Reply

Amccorrie Aug. 18 at 8:03 PM

$IXHL Entertaining how when this starts to go back up again slowly, all the new bears and existing ones come out trying to scare people so they can close their positions. Low volume traps them in. Let them pay for their stupidity they had their chance to get out. If after the not great 13F’s this is holding, then it’s not likely it will drop much further. Unless we get some genuinely bad news. Instead we have potential DReAMzz updates and news on PSX before too long. 🤷🏻‍♂️ Short interest is increasing and there is still a high short float. If it carries on like this there might be a small squeeze before long.

2 · Reply

Rampart1 Aug. 18 at 7:47 PM

$IXHL all you need to know. Another lady boy troll.

0 · Reply

Rampart1 Aug. 18 at 7:46 PM

$IXHL how is sideways not a win? Considering it was going down so much. Great thing is I can use the block. Have a good life. I ❤️ block button.

0 · Reply

nobodyyk Aug. 18 at 6:45 PM

$IXHL I thought August was the month Indiana J

1 · Reply

malibu_rum67 Aug. 18 at 5:40 PM

$IXHL … Very

1 · Reply

nmzl Aug. 18 at 5:39 PM

$IXHL Joel is on a noble mission to help retail make money and not institutions.. Institutions also believe that only retail has to win and they have sold.. Hope he delivers on this soon.

1 · Reply

Market Cap	39.66M
Revenue (ttm)	90,000.00
Net Income (ttm)	-46.89M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-52,100.00%
Debt to Equity Ratio	0.00

Volume	101,700
Avg Vol	214,474
Day's Range	N/A - N/A
Shares Out	11.97M
Stochastic %K	81%
Beta	6.98
Analysts	Hold
Price Target	$18.00